NUVL
NUVALENT-A (NUVL)
NASDAQ
$123.45+$0.02 (+0.02%)
Price as of Jun 23, 2026 3:34 PM EDT
  • $9.1B
    Market Cap
  • 62.44%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-307.0M
+40.96%
-217.8M
+92.31%
-113.2M
+77.69%
-63.7M
+79.23%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
414.3M
+47.77%
280.4M
+87.55%
149.5M
+73.61%
86.1M
+87.94%
Operating Profit
-414.3M
+47.77%
-280.4M
+87.55%
-149.5M
+73.61%
-86.1M
+87.94%
Interest Income
44.8M
+16.67%
38.4M
N/A
N/A
N/A
4.3M
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
44.8M
+16.67%
38.4M
N/A
0
-100.00%
4.3M
N/A
Total Nonoperating Income and Expense
-10.5M
-151.46%
20.4M
-12.45%
23.3M
+447.09%
4.3M
+916.51%
Income before Taxes
-424.8M
+63.39%
-260.0M
+73.92%
-149.5M
+73.61%
-86.1M
+87.94%
Income Taxes
585,000
-23.43%
764,000
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-425.4M
+63.13%
-260.8M
+106.59%
-126.2M
+54.20%
-81.9M
+76.65%
Net Income from Continuing Operations Applicable to Common
-424.8M
+63.39%
-260.0M
+105.98%
-126.2M
+54.20%
-81.9M
+76.65%
Basic EPS and Net Income
-5.85
+48.85%
-3.93
+81.11%
-2.17
+31.52%
-1.65
-22.54%
Diluted EPS and Net Income
-5.85
+48.85%
-3.93
+81.11%
-2.17
+31.52%
-1.65
-22.54%
Basic Weighted Average Shares
72.7M
+9.45%
66.4M
+14.06%
58.2M
+17.22%
49.7M
+128.01%
Diluted Weighted Average Shares
72.7M
+9.45%
66.4M
+14.06%
58.2M
+17.22%
49.7M
+128.01%
Balance Sheet
Cash and Cash Equivalents
261.7M
+79.66%
145.7M
-56.56%
335.4M
+38.70%
241.8M
+252.87%
Short-Term Investments
1.1B
+14.15%
972.6M
+152.94%
384.5M
+66.92%
230.4M
+4.91%
Cash and Cash Equivalents and Short-Term Investments
1.4B
+22.68%
1.1B
+55.34%
719.9M
+52.47%
472.2M
+63.88%
Total Current Assets
1.4B
+22.96%
1.1B
+55.88%
726.5M
+51.99%
478.0M
+64.47%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
20.3M
+117.96%
9.3M
+57.80%
5.9M
+31.96%
4.5M
+39.80%
Total Assets
1.4B
+23.73%
1.1B
+55.90%
732.4M
+51.80%
482.5M
+64.20%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
91.2M
+68.77%
54.0M
+69.75%
31.8M
+63.35%
19.5M
+121.70%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
2.0M
0.00%
Total Long-Term Liabilities
35,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
164.4M
+128.41%
72.0M
+126.13%
31.8M
+63.35%
19.5M
+121.70%
Retained Earnings
-972.4M
+77.76%
-547.1M
+91.08%
-286.3M
+78.85%
-160.1M
+104.64%
Total Stockholders Equity
1.2B
+16.69%
1.1B
+52.71%
700.6M
+51.32%
463.0M
+62.43%
Total Shares Outstanding
72.8M
+1,239.48%
5.4M
-91.52%
64.1M
+13.05%
56.7M
+17.33%
Cash Flow
Cash from Operating Activities
-275.2M
+48.71%
-185.1M
+85.55%
-99.7M
+53.51%
-65.0M
+62.43%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-124.1M
-78.37%
-573.5M
+299.59%
-143.5M
+1,245.78%
-10.7M
-95.15%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
515.3M
-9.41%
568.9M
+68.88%
336.8M
+35.33%
248.9M
-21.78%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-33.30%
+19.69%
-27.83%
+33.91%
-20.78%
-1.47%
-21.09%
N/A
Return on Equity
-36.70%
+24.58%
-29.46%
+35.78%
-21.70%
-0.87%
-21.89%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
15.27
-27.15%
20.96
-8.17%
22.83
-6.96%
24.54
N/A
Cash Ratio
2.87
+6.45%
2.70
-74.41%
10.54
-15.09%
12.41
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow